AbCellera Biologics (ABCL) Earnings Date & Reports

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ABCL is expected to report earnings to fall 3.33% to -17 cents per share on November 10

AbCellera Biologics ABCL Stock Earnings Reports

Q3'26

Est.

$-0.17

Q2'26

Missed

by $0.01

Q1'26

Beat

by $0.01

Q4'25

Missed

by $0.35

Q3'25

Missed

by $0.05

The last earnings report on August 05 showed earnings per share of -18 cents, missing the estimate of -17 cents. With 9.24M shares outstanding, the current market capitalization sits at 3.37B.

View a ticker or compare two or three

ABCL

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days